Form 4 for IMNM Immunome Inc.
Accepted 2025-02-03 00:00:00 ET · period of report 2025-01-31 · accession 0001415889-25-002824 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-03 | 2025-01-31 | IMNM | SIEGALL CLAY B | Pres, CEO, Dir | P - Purchase | $7.75 | +150.0K | 669.6K | +29% | +$1.16M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-31 | P | A | 150,000 | $7.75 | 669,636 | D | — | — |